Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2007 June; 8(2): E105–E109.
Published online 2007 June 8. doi:  10.1208/pt0802043
PMCID: PMC2750358

Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity


The purpose of this study was to investigate the formation of acylated impurity resulting from a chemical reaction between the growth hormone-releasing peptide-6 (GHRP-6) and poly(lactide-co-glycolide) (PLGA) and the effect of peptide acylation on the in vivo biological activity of GHRP-6. The peptide acylation pattern of GHRP-6 by hydrophilic PLGA polymers with different molecular weights was characterized by reversed-phase high-performance liquid chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Higher levels of acylated GHRP-6 were produced with the higher molecular weight PLGA, which might be due to the slower degradation rate of the polymer. The evaluation of the biological activity in rats showed that the acylated GHRP-6 had a much lower activity than the intact GHRP-6. This finding suggests that the acylation reaction would decrease the effectiveness of the GHRP-6 formulation such as PLGA microspheres. There-fore, a strategy for stabilizing the GHRP-6 will be necessary for the development of a successful formulation of PLGA microspheres.

Keywords: Poly(lactide-co-glycolide), microspheres, peptide acylation, stability, growth hormone releasing peptide-6

Full Text

The Full Text of this article is available as a PDF (250K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Gombotz WR, Pettit DK. Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem. 1995;6:332–351. doi: 10.1021/bc00034a002. [PubMed] [Cross Ref]
2. Sinha VR, Trehan A. Biodegradable microspheres for parenteral delivery. Crit Rev Ther Drug Carrier Syst. 2005;22:535–602. [PubMed]
3. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev. 1997;28:25–42. doi: 10.1016/S0169-409X(97)00049-5. [PubMed] [Cross Ref]
4. DeLuca PP, Woo BW, Jiang G, Jo YW. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18:1600–1606. doi: 10.1023/A:1013090700443. [PubMed] [Cross Ref]
5. Murty SB, Wei Q, Thanoo BC, DeLuca PP. In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes. AAPS PharmSciTech. 2004;5:E49–E49. doi: 10.1208/pt050349. [PMC free article] [PubMed] [Cross Ref]
6. Van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res. 2000;17:1159–1167. doi: 10.1023/A:1026498209874. [PubMed] [Cross Ref]
7. Bilati U, Allemann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles. Eur J Pharm Biopharm. 2005;59:375–388. doi: 10.1016/j.ejpb.2004.10.006. [PubMed] [Cross Ref]
8. Lucke A, Kiermaier J, Gopferich A. Peptide acylation by poly(alpha-hydroxy esters) Pharm Res. 2002;19:175–181. doi: 10.1023/A:1014272816454. [PubMed] [Cross Ref]
9. Na DH, Youn YS, Lee SD, et al. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J Control Release. 2003;92:291–299. doi: 10.1016/S0168-3659(03)00366-3. [PubMed] [Cross Ref]
10. Na DH, Murty SB, Lee KC, Thanoo BC, DeLuca PP. Preparation and stability of PEGylated octreotide for application to microsphere delivery. AAPS PharmSciTech. 2003;4:E72–E72. doi: 10.1208/pt040472. [PMC free article] [PubMed] [Cross Ref]
11. Murty SB, Goodman J, Thanoo BC, DeLuca PP. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech. 2003;4:E50–E50. doi: 10.1208/pt040450. [PMC free article] [PubMed] [Cross Ref]
12. Murty SB, Thanoo BC, Wei Q, DeLuca PP. Impurity formation studies with peptide-loaded polymeric micropheres. I. In vivo evaluation. Int J Pharm. 2005;297:50–61. doi: 10.1016/j.ijpharm.2005.02.035. [PubMed] [Cross Ref]
13. Murty SB, Na DH, Thanoo BC, DeLuca PP. Impurity formation studies with peptide-loaded polymeric microspheres. II. In vitro evaluation. Int J Pharm. 2005;297:62–72. doi: 10.1016/j.ijpharm.2005.02.034. [PubMed] [Cross Ref]
14. Na DH, DeLuca PP. PEGylation of octreotide. I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-coglycolide) Pharm Res. 2005;22:736–742. doi: 10.1007/s11095-005-2589-4. [PubMed] [Cross Ref]
15. Na DH, Lee KC, DeLuca PP. PEGylation of octreotide. II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics. Pharm Res. 2005;22:743–749. doi: 10.1007/s11095-005-2590-y. [PubMed] [Cross Ref]
16. Camanni F, Ghigo E, Arvat E. Growth hormone-releasing peptides and their analogs. Front Neuroendocrinol. 1998;19:47–72. doi: 10.1006/frne.1997.0158. [PubMed] [Cross Ref]
17. Na DH, DeLuca PP, Lee KC. Direct determination of the peptide content in microspheres by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem. 2004;76:2669–2673. doi: 10.1021/ac035477i. [PubMed] [Cross Ref]
18. Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(d,I-lactide-co-glycolide) J Control Release. 1996;41:249–257. doi: 10.1016/0168-3659(96)01332-6. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists